Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis
- PMID: 7914213
- DOI: 10.1007/BF03347719
Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis
Abstract
Following the recent identification of specific germline mutations of the RET proto-oncogene in Multiple Endocrine Neoplasia type 2A (MEN2A) patients, we looked for mutations of this gene in a pedigree showing recurrence of MEN2A and localized Cutaneous Lichen Amyloidosis (CLA). Basal calcitonin and/or pentagastrin test performed in all the 10 available members of this pedigree confirmed the clinical diagnosis and allowed the presymptomatic identification of an additional carrier. A cys634-->tyr missense mutation, already reported as causative in MEN2A patients, was identified after SSCP analysis and direct sequencing of exon 11 of the RET protooncogene in one individual affected with both MEN2A and CLA, thus suggesting a common etiology for the two disorders. Taking advantage of the observation of an RsaI restriction site in the sequence surrounding the mutated codon, we could demonstrate that the same mutation is present in three other affected members, in the presymptomatic carrier and in one additional 25 years old healthy member who shows a mildly positive pentagastrin test.
Similar articles
-
Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).Endocr J. 1995 Aug;42(4):527-36. doi: 10.1507/endocrj.42.527. Endocr J. 1995. PMID: 8556060
-
A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis.Clin Genet. 1997 Feb;51(2):86-90. doi: 10.1111/j.1399-0004.1997.tb02425.x. Clin Genet. 1997. PMID: 9111993
-
Multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis: description of a new family.J Endocrinol Invest. 1993 Apr;16(4):295-6. doi: 10.1007/BF03348840. J Endocrinol Invest. 1993. PMID: 8099921
-
MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.Fam Cancer. 2016 Oct;15(4):625-33. doi: 10.1007/s10689-016-9892-6. Fam Cancer. 2016. PMID: 26920351 Review.
-
Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.Eur J Endocrinol. 2008 Dec;159(6):767-71. doi: 10.1530/EJE-08-0476. Epub 2008 Sep 19. Eur J Endocrinol. 2008. PMID: 18805915 Review.
Cited by
-
The RET C611Y mutation causes MEN 2A and associated cutaneous.Endocr Connect. 2018 Sep 1;7(9):998-1005. doi: 10.1530/EC-18-0220. Endocr Connect. 2018. PMID: 30300539 Free PMC article.
-
Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing.J Biosci. 2017 Jun;42(2):209-218. doi: 10.1007/s12038-017-9686-5. J Biosci. 2017. PMID: 28569245
-
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335. Thyroid. 2015. PMID: 25810047 Free PMC article. Review.
-
Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.J Clin Invest. 1995 Oct;96(4):1786-93. doi: 10.1172/JCI118224. J Clin Invest. 1995. PMID: 7560070 Free PMC article.
-
5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.Front Endocrinol (Lausanne). 2020 Sep 18;11:543246. doi: 10.3389/fendo.2020.543246. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071967 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases